These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 31647624)
1. [Amisulpride, a one-of-a-kind and highly efficacious antipsychotic agent in the treatment of first-episode psychosis]. Luykx JJ; Kraats GV; van Ojen R Ned Tijdschr Geneeskd; 2019 Oct; 163():. PubMed ID: 31647624 [TBL] [Abstract][Full Text] [Related]
2. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study. Kahn RS; Winter van Rossum I; Leucht S; McGuire P; Lewis SW; Leboyer M; Arango C; Dazzan P; Drake R; Heres S; Díaz-Caneja CM; Rujescu D; Weiser M; Galderisi S; Glenthøj B; Eijkemans MJC; Fleischhacker WW; Kapur S; Sommer IE; Lancet Psychiatry; 2018 Oct; 5(10):797-807. PubMed ID: 30115598 [TBL] [Abstract][Full Text] [Related]
3. A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design. Schmidt-Kraepelin C; Feyerabend S; Engelke C; Riesbeck M; Meisenzahl-Lechner E; Gaebel W; Verde PE; Kolbe H; Correll CU; Leucht S; Heres S; Kluge M; Makiol C; Neff A; Lange C; Englisch S; Zink M; Langguth B; Poeppl T; Reske D; Gouzoulis-Mayfrank E; Gründer G; Hasan A; Brockhaus-Dumke A; Jäger M; Baumgärtner J; Wobrock T; Cordes J Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):83-94. PubMed ID: 31486890 [TBL] [Abstract][Full Text] [Related]
4. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone]. Bret P; Bonnet F; Bret MC; Jaffré A Encephale; 2002; 28(4):329-42. PubMed ID: 12232542 [TBL] [Abstract][Full Text] [Related]
5. A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort). Ter Hark SE; Jamain S; Schijven D; Lin BD; Bakker MK; Boland-Auge A; Deleuze JF; Troudet R; Malhotra AK; Gülöksüz S; Vinkers CH; Ebdrup BH; Kahn RS; Leboyer M; Luykx JJ J Psychopharmacol; 2020 May; 34(5):524-531. PubMed ID: 32126890 [TBL] [Abstract][Full Text] [Related]
6. The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics. Leucht S; Winter-van Rossum I; Heres S; Arango C; Fleischhacker WW; Glenthøj B; Leboyer M; Leweke FM; Lewis S; McGuire P; Meyer-Lindenberg A; Rujescu D; Kapur S; Kahn RS; Sommer IE Schizophr Bull; 2015 May; 41(3):549-58. PubMed ID: 25786408 [TBL] [Abstract][Full Text] [Related]
7. Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial. Howard R; Cort E; Bradley R; Harper E; Kelly L; Bentham P; Ritchie C; Reeves S; Fawzi W; Livingston G; Sommerlad A; Oomman S; Nazir E; Nilforooshan R; Barber R; Fox C; Macharouthu AV; Ramachandra P; Pattan V; Sykes J; Curran V; Katona C; Dening T; Knapp M; Gray R; Lancet Psychiatry; 2018 Jul; 5(7):553-563. PubMed ID: 29880238 [TBL] [Abstract][Full Text] [Related]
8. A Case Report of Clozapine-Associated Stuttering and Amisulpride-Associated Stuttering and Seizure in an Adult on Concurrent Fluoxetine Therapy. Mathur R; Singh J; Sood M J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):330-332. PubMed ID: 33675589 [No Abstract] [Full Text] [Related]
10. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
12. Severe clozapine-induced agranulocytosis: successful treatment with G-CSF and rechallenge of clozapine plus D2 potentiation therapy (amisulpride). Ruiz-Doblado S; Plasencia-García de Diego B; Perea-Pérez R; Jiménez-Gonzalo F Actas Esp Psiquiatr; 2020 Mar; 48(2):89-91. PubMed ID: 32463914 [No Abstract] [Full Text] [Related]
13. Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study. Genç Y; Taner E; Candansayar S Adv Ther; 2007; 24(1):1-13. PubMed ID: 17526456 [TBL] [Abstract][Full Text] [Related]
14. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia. Cook B; Hoogenboom G Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745 [TBL] [Abstract][Full Text] [Related]
16. [Acute tongue and pharyngeal spasms during changeover from clozapine to amisulpride. A case example]. Jatzko A; Ries S; Schreiner A; Braus DF Nervenarzt; 2000 Nov; 71(11):919-22. PubMed ID: 11103369 [TBL] [Abstract][Full Text] [Related]
17. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis. Smith RC; Leucht S; Davis JM Psychopharmacology (Berl); 2019 Feb; 236(2):545-559. PubMed ID: 30506237 [TBL] [Abstract][Full Text] [Related]
18. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074 [TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia. Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726 [TBL] [Abstract][Full Text] [Related]
20. The Management of Very Early-Onset Schizophrenia With an Olanzapine and Amisulpride Combination. Karal BN; Özdemir YE; Karayağmurlu A J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):427-429. PubMed ID: 38695720 [No Abstract] [Full Text] [Related] [Next] [New Search]